212 related articles for article (PubMed ID: 16036090)
1. Postmenopausal osteoporosis.
Selby P
Curr Osteoporos Rep; 2004 Sep; 2(3):101-6. PubMed ID: 16036090
[TBL] [Abstract][Full Text] [Related]
2. Clinical inquiries. What is the best approach to prevention and treatment of osteoporosis?
Schwartz K; Chang SI
J Fam Pract; 2001 Dec; 50(12):1024-5. PubMed ID: 11742601
[No Abstract] [Full Text] [Related]
3. Combination/sequential therapy in osteoporosis.
Lecart MP; Bruyere O; Reginster JY
Curr Osteoporos Rep; 2004 Dec; 2(4):123-30. PubMed ID: 16036093
[TBL] [Abstract][Full Text] [Related]
4. [Osteoporosis therapy in general practice. Which measure should be included?].
Abendroth K
MMW Fortschr Med; 2002 Oct; 144(42):62. PubMed ID: 12534001
[No Abstract] [Full Text] [Related]
5. Effective strategies to identify postmenopausal women at risk for osteoporosis.
Levine JP
Geriatrics; 2007 Nov; 62(11):22-30. PubMed ID: 17999567
[TBL] [Abstract][Full Text] [Related]
6. Use of highly potent bisphosphonates in the treatment of osteoporosis.
McClung M
Curr Osteoporos Rep; 2003 Dec; 1(3):116-22. PubMed ID: 16036074
[TBL] [Abstract][Full Text] [Related]
7. Postmenopausal hormone use and skeletal fracture: does the size of the benefit decrease with increasing age?
Weiss NS; Treggiari MM
Obstet Gynecol; 2002 Aug; 100(2):364-8. PubMed ID: 12151165
[TBL] [Abstract][Full Text] [Related]
8. Menostar: a low-dose estrogen patch for osteoporosis.
Obstet Gynecol; 2005 Feb; 105(2):432-3. PubMed ID: 15684177
[No Abstract] [Full Text] [Related]
9. Seeking clarification of osteoporosis guidelines.
Sehmer J
CMAJ; 2004 Oct; 171(9):1022; author reply 1022-3. PubMed ID: 15505246
[No Abstract] [Full Text] [Related]
10. [Preventive drug therapy of postmenopausal osteoporosis].
Chaouat D; Tsouderos Y
Rev Med Interne; 1993; 14(9):877-87. PubMed ID: 8191108
[TBL] [Abstract][Full Text] [Related]
11. [Osteoporosis: basics and pitfalls].
Rafeiner P
Praxis (Bern 1994); 2007 Jan; 96(4):101-6. PubMed ID: 17294585
[TBL] [Abstract][Full Text] [Related]
12. [Large clinical trials for osteoporosis].
Meunier PJ
Therapie; 2003; 58(5):415-20. PubMed ID: 14682189
[TBL] [Abstract][Full Text] [Related]
13. Fracture prevention in postmenopausal women.
Mosekilde L; Vestergaard P; Langdahl B
Clin Evid; 2006 Jun; (15):1543-60. PubMed ID: 16973058
[No Abstract] [Full Text] [Related]
14. Antiresorptive treatment of postmenopausal osteoporosis: comparison of study designs and outcomes in large clinical trials with fracture as an endpoint.
Marcus R; Wong M; Heath H; Stock JL
Endocr Rev; 2002 Feb; 23(1):16-37. PubMed ID: 11844743
[TBL] [Abstract][Full Text] [Related]
15. Treatment of postmenopausal osteoporosis.
Reginster JY
BMJ; 2005 Apr; 330(7496):859-60. PubMed ID: 15831851
[No Abstract] [Full Text] [Related]
16. Pharmacologic management of osteoporosis.
Aynardi M; Ilyas AM
J Hand Surg Am; 2013 Mar; 38(3):588-92. PubMed ID: 23312206
[No Abstract] [Full Text] [Related]
17. Beyond bone mineral density: several factors define bone health.
Ruhl C
Nurs Womens Health; 2008 Jun; 12(3):249-51. PubMed ID: 18557856
[No Abstract] [Full Text] [Related]
18. Therapies to improve bone mineral density and reduce the risk of fracture: clinical trial results.
Watts NB
J Reprod Med; 2002 Jan; 47(1 Suppl):82-92. PubMed ID: 11829081
[TBL] [Abstract][Full Text] [Related]
19. [Effects of SERMs on bone health. Discrimination of SERMs from bisphosphonates in the treatment of postmenopausal osteoporosis].
Iwamoto J
Clin Calcium; 2010 Mar; 20(3):396-407. PubMed ID: 20190370
[TBL] [Abstract][Full Text] [Related]
20. The safety and tolerability profile of therapies for the prevention and treatment of osteoporosis in postmenopausal women.
Komm BS; Morgenstern D; A Yamamoto L; Jenkins SN
Expert Rev Clin Pharmacol; 2015; 8(6):769-84. PubMed ID: 26482902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
